Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.48 -0.08 (-5.12%)
As of: Oct 2, 2026 · 1:45 PM EDT

Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021)

Updated

Cardiol Therapeutics (CRDL) posted Depreciation & Amortization - Total of $27,261 for Q2 2021, up 4.0% from $26,206 a year earlier.

Analysis

Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cardiol Therapeutics 166.43 Mn 166.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 27,261.30
Jun 30, 2020 26,206.39
API Access

Cardiol Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=CRDL&period=max&api_key=YOUR_API_KEY